Online first
Letter to the Editor
Published online: 2024-09-27

open access

Page views 58
Article views/downloads 37
Get Citation

Connect on Social Media

Connect on Social Media

Investigating biomarkers: a path to understanding long-COVID?

Oskar Szymański1, Magdalena Grzesiak1
DOI: 10.5603/mrj.102231

Abstract

< p > < /p >

Article available in PDF format

View PDF Download PDF file

References

  1. Smykiewicz J, Wiacek M, Buczkowski J, et al. Markers of the outcome of COVID-19. Med Res J. 2024.
  2. Ranjbar M, Cusack RP, Whetstone CE, et al. Immune Response Dynamics and Biomarkers in COVID-19 Patients. Int J Mol Sci. 2024; 25(12).
  3. Ballering AV, van Zon SKR, Olde Hartman TC, et al. Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022; 400(10350): 452–461.
  4. Thaweethai T, Jolley SE, Karlson EW, et al. RECOVER Consortium. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023; 329(22): 1934–1946.
  5. Zanini G, Selleri V, Roncati L, et al. Vascular "Long COVID": A New Vessel Disease? Angiology. 2024; 75(1): 8–14.
  6. Cervia-Hasler C, Brüningk SC, Hoch T, et al. Persistent complement dysregulation with signs of thromboinflammation in active Long Covid. Science. 2024; 383(6680): eadg7942.